Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Timothy C. Thompson, Chengzhen Ren et al.|Oncotarget|2016Cited by 31
The aggressive variant prostate carcinoma (AVPC) molecular signature (-MS) and platinum-sensitivity in castration resistant prostate cancer (CRPC).Ana M. Aparicio, Paul G. Corn, Lianchun Xiao et al.|Journal of Clinical Oncology|2017Cited by 20
A phase II trial of apalutamide for intermediate‐risk prostate cancer and molecular correlatesAndrew W. Hahn, John W. Davis, Ganiraju C. Manyam et al.|British Journal of Urology|2024Cited by 4